AzTrials
AzTrials

Women (Between 18 to 50 Years Old)agingNCT07132346

Are Women Hesitant to Become Mothers in the New World?

An observational study of Women (Between 18 to 50 Years Old), run by University of Gaziantep at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The decision to have a child can be perceived as indecisive, and women who experience maternal indecisiveness avoid pregnancy. However, as women age, fertility anxiety also increases. Read more about this study

Who is it for?
Ages 20 years and older, women only
Conditions the study is for
Women (Between 18 to 50 Years Old)
What is being tested?
AGING ANXIETY SCALE
How many people
300 participants
Where
1 siteTurkey (Türkiye)
Study dates
14 Jul 2024to 15 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: The population of the study consisted of women aged ≥20 years who applied to the obstetrics and gynecology clinic of XXX hospital for any reason. A literature review was conducted and a power analysis was performed on the G-power 3.9.1 software to calculate the sample size following a literature review (Guney et al., 2022; Gipson et al., 2021). The minimum sample size required to expect a significant relationship with a large effect size (Cohen's d=0.0784314) in terms of women's tendency to avoid pregnancy was found to be 300 individuals (α=0.05, 1-β=0.95). Totally, 312 women were reached, but 12 were not included in the study as they dropped out. Eventually, the study sample consisted of 300 women.

Who may be able to join

  • Volunteering to participate in the study,
  • Having no communication barriers,
  • Age ≥20 years, and
  • Being married.

Who cannot join

  • Unwilling to participate in the study,
  • Having a psychiatric health problem according to medical records,
  • Being single, and
  • Being pregnant.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gaziantep University

    Gaziantep

Other trials in Turkey (Türkiye)

About this study

Official title: "Are Women Hesitant to Become Mothers in the New World?"

The decision to have a child can be perceived as indecisive, and women who experience maternal indecisiveness avoid pregnancy. However, as women age, fertility anxiety also increases. The investigators aimed to investigate the mediating role of aging anxiety in the relationship between maternal ambivalence and avoidance of pregnancy in women.

Read the detailed description

The decision to have a child can be perceived as indecisive, and women who experience maternal indecisiveness avoid pregnancy. However, as women age, fertility anxiety also increases. We aimed to investigate the mediating role of aging anxiety in the relationship between maternal ambivalence and avoidance of pregnancy in women. Data collection tools included a "Personal Information Form," "the Maternal Ambivalence Scale," "the Desire to Avoid Pregnancy Scale," and "The Relational Aging Anxiety Scale." Regression models assessed the association between Maternal Ambivalence Scale, Desire to Avoid Pregnancy Scale and Relational Aging Anxiety Scale. SPSS Process v.3.4 analysis was performed to make a mediator effect assessment. It was found that the model was significant and 3% of the desire to avoid pregnancy was explained by maternal ambivalence (F=9.088; p=0.003) (n=300). Since the confidence interval (95% CI [0.019; 0.096]) of the indirect effect did not include "0", a mediating effect was detected. It was found that the model was significant and 17.6% of the desire to avoid pregnancy was explained by the doubts sub-dimension (F=9.477; p=0.002). Since the confidence interval (95% CI [0.024; 0.200]) of the indirect effect did not include "0", a mediating effect was identified. The collective affinity for older people sub-dimension had a partial mediating effect between rejection and the desire to avoid pregnancy. Results indicated that 20.5% of the total effect on the desire to avoid pregnancy was provided by the mediating effect. It was found that women's perceptions of aging caused maternal ambivalence and that this situation was effective in avoiding pregnancy.

Being tested
AGING ANXIETY SCALE
Keywords
maternal ambivalence, avoiding pregnancy, women, aging anxiety

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AGING ANXIETY SCALEOther

    This study was conducted as descriptive research to determine the mediating role of aging anxiety in the relationship between maternal ambivalence and pregnancy avoidance in women.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. "the Maternal Ambivalence Scale"

    The study sample consisted of 300 women. Their written and verbal consent was obtained.

    The Maternal Ambivalence Scale: The scale has 14 four-point Likert-type items, each of which is scored between 1 and 4. The minimum total score that can be obtained from the scale is 14, and the maximum is 56. An increase in the total score indicates a high level of maternal ambivalence. The scale has three sub-dimensions.

    Measured: 3 MONTHS

  2. The Desire to Avoid Pregnancy Scale

    The Desire to Avoid Pregnancy Scale: The five-point Likert-type items on the scale are scored using the following options: "0= strongly agree" and "4= strongly disagree. Scores on the scale range from 0/14=0 to 56/14=4. A high score obtained from the scale indicates an increase in the desire to avoid pregnancy, while a low score shows a decrease in this respect.

    Measured: 3 months

  3. The Relational Aging Anxiety Scale

    The Relational Aging Anxiety Scale: Items are scored on a five-point Likert-type scale from (1) strongly agree to (5) strongly disagree. The scale consists of three sub-dimensions. The scale does not have a total score.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2025
  2. Study start14 Jul 2024
  3. Primary completion14 Oct 2024
  4. Study completion15 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
300 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07132346
Sponsor's protocol ID
GAUN-EBE-EKD-02
Other IDs
UGaziantep
Acronym
aging
Status last verified
Jul 2025
First submitted
23 Jul 2025
Last updated
20 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Women (Between 18 to 50 Years Old), run by University of Gaziantep at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

"the Maternal Ambivalence Scale" (time frame: 3 MONTHS). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in